-- ReportsnReports.com adds new research report on Low Back Pain - Pipeline Review, H1 2017. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Browse the 37 Tables and 10 Figures, 23 Company Profiles, Spread across 96 Pages Report Available at http://www.reportsnreports.com/reports/992888-low-back-pain-pipeline-review-h1-2017.html .
Low Back Pain Market- Drug Profiles - AB-001, AMG-0101, ARRY-954, AYX-2, bupivacaine, cebranopadol, dexmedetomidine hydrochloride, fasinumab, HP-3150, IG-8801, lidocaine hydrochloride, MD-22, MPC-06ID, NKTR-181, oxycodone hydrochloride ER, SPARC-1401, STA-363, tanezumab many more..
Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving the spine. Symptoms include tingling or burning sensation, a dull achy feeling, or sharp pain and weakness in legs or feet. Treatment includes pain medications such NSAIDs (non-steroidal anti-inflammatory drugs) or opioids and muscle relaxants.
Low Back Pain - Companies Involved in Therapeutics Development - Ache Laboratorios Farmaceuticos SA, Adynxx Inc, AnGes MG Inc, Array BioPharma Inc, Axsome Therapeutics Inc, Boehringer Ingelheim GmbH, Egalet Corp, Frontier Biotechnologies Co Ltd, Gador SA, Grunenthal GmbH, Hisamitsu Pharmaceutical Co Inc, Huons Co Ltd, Immune Pharmaceuticals Inc, KPI Therapeutics Inc, MD Biosciences GmbH, Mesoblast Ltd, Nektar Therapeutics, Orion Oyj, Pacira Pharmaceuticals Inc, Pfizer Inc, Regeneron Pharmaceuticals Inc, Stayble Therapeutics AB, Sun Pharma Advanced Research Company Ltd
Place Order to This Report at http://www.reportsnreports.com/purchase.aspx?name=992888 .
The Low Back Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 6, 9, 2, 1 and 6 respectively.
Low Back Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Discount of this report http://www.reportsnreports.com/contacts/discount.aspx?name=992888
Scope
• The pipeline guide provides a snapshot of the global therapeutic landscape of Low Back Pain (Central Nervous System).
• The pipeline guide reviews pipeline therapeutics for Low Back Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Low Back Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Low Back Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Low Back Pain (Central Nervous System)
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: ReportsnReports.com
Website: http://www.reportsnreports.com/reports/992888-low-back-pain-pipeline-review-h1-2017.html
Release ID: 200050
Google
RSS